Learning Cost-Effective and Interpretable Regimes for Treatment Recommendation
Himabindu Lakkaraju, Cynthia Rudin

TL;DR
This paper introduces a method to learn cost-effective, interpretable treatment decision lists that maximize outcomes and minimize costs, using a novel MDP-based approach with UCT for efficient search, validated on asthma treatment data.
Contribution
It presents a new framework for learning decision lists that balance outcomes and costs, employing a Markov Decision Process and UCT-based search for improved interpretability and efficiency.
Findings
Effective in optimizing treatment outcomes and costs
Demonstrated success on real-world asthma data
Outperforms baseline methods in interpretability and efficiency
Abstract
Decision makers, such as doctors and judges, make crucial decisions such as recommending treatments to patients, and granting bails to defendants on a daily basis. Such decisions typically involve weighting the potential benefits of taking an action against the costs involved. In this work, we aim to automate this task of learning {cost-effective, interpretable and actionable treatment regimes. We formulate this as a problem of learning a decision list -- a sequence of if-then-else rules -- which maps characteristics of subjects (eg., diagnostic test results of patients) to treatments. We propose a novel objective to construct a decision list which maximizes outcomes for the population, and minimizes overall costs. We model the problem of learning such a list as a Markov Decision Process (MDP) and employ a variant of the Upper Confidence Bound for Trees (UCT) strategy which leverages…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAdvanced Causal Inference Techniques · Machine Learning in Healthcare · Statistical Methods in Clinical Trials
